-- Biogen (BIIB) has an average rating of overweight and mean price target of $213.07, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)